• Explore /
  • Poster
  • / Outcomes of elderly patients (pts) treated with docetaxel (DOC) for metastatic castration-sensitive prostate cancer (mCSPC): Results from ECHOS, a multicenter Italian observational study.

Outcomes of elderly patients (pts) treated with docetaxel (DOC) for metastatic castration-sensitive prostate cancer (mCSPC): Results from ECHOS, a multicenter Italian observational study.

Abstract Poster

Authors

null

Orazio Caffo

Medical Oncology Department, APSS Santa Chiara Hospital, Trento, Italy

Orazio Caffo , Marco Maruzzo , Federico Pravisano , Consuelo ButtIgliero , Mariella Sorarù , Cristina Masini , Stefania Gori , Roberto Sabbatini , Annalisa Pappalardo , Carlo Cattrini , Giuseppe Fornarini , Isabella Vittimberga , Alessandro Rametta , Paolo Andrea Zucali , Emanuela Fantinel , Francesco Grillone , Lucia Fratino , Luca Galli , Monica Giordano , Umberto Basso

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer - Advanced,Prostate Cancer - Localized

Sub Track

Therapeutics

Citation

J Clin Oncol 42, 2024 (suppl 4; abstr 153)

DOI

10.1200/JCO.2024.42.4_suppl.153

Abstract #

153

Poster Bd #

G3

Abstract Disclosures

Similar Posters

First Author: Orazio Caffo

First Author: Michael Paul Kolinsky

First Author: Christopher J.D. Wallis

Poster

2024 ASCO Genitourinary Cancers Symposium

Survival Outcomes of APA as a Starting treatment: Impact in real-world patients with mCSPC (OASIS)

Survival Outcomes of APA as a Starting treatment: Impact in real-world patients with mCSPC (OASIS)

First Author: Benjamin L. Maughan